Drug Research
Takeda and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease
Takeda Pharmaceutical Company Limited and PvP Biologics, Inc announced a global agreement for the development of KumaMax, a novel enzyme designed to break down...
Articles
Applying New Approaches to Containment and Delivery of Diabetes Medications
Type 2 diabetes awareness is rising in the United States. Public and private health leaders are now offering screenings and patient education sites that...
Press Releases
Global pharma players trust in Swisslog to strengthen intralogistics
Swisslog, a leading automation expert for robot-based and data driven intralogistic solutions, has completed the latest expansion of the high-bay warehouse for healthcare manufacturers....
White Papers
Six Trends in Pharma Marketing
Embracing Digital Transformation in the Pharma and Healthcare Sectors A Marketer’s Guide The New Reality:Nearly everything healthcare and pharma marketers did...
Clinical Trials
Renova Therapeutics selects Worldwide Clinical Trials as its CRO for RT-100 AC6 gene transfer
Renova  Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes. Announced that it has...
Production & Manufacturing
Prokarium and Probiomed Scale Up Manufacture of Oral Vaccines
Biotech firms Prokarium and Probiomed have announced a collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability...
Industry Reports
OncoGenex Pharmaceuticals and Achieve Life Science Announce Definitive Merger Agreement
OncoGenex Pharmaceuticals, Inc , a publicly held oncology biopharmaceutical company, and Achieve Life Science, Inc , a privately held specialty pharmaceutical company, announced that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read